Please assess the completion status of the following clinical trial:

Trial Title: Hand, Foot, and Mouth Disease: Could EPs®7630 be a Treatment Option

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: PHASE2/PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~-Patients diagnosed with Hand, foot, and mouth disease~Exclusion Criteria:~* Patients whose complaints lasted more than 48 hours~* Unable to comply with follow-ups,~* Did not give informed consent,~* Another antiviral or supportive treatment,~* Use antibiotics in the previous 1 month,~* A history of immunodeficiency or a family history of immunodeficiency,~* A previous history of anaphylaxis with any supplement or drug,~* Any chronic disease, or skin lesion -

- Gender: ALL
- Minimum Age: 1 Year
- Maximum Age: 10 Years
- Healthy Volunteers: f

Study Arms:
- EPs® 7630 group (Type: ACTIVE_COMPARATOR): The patients were divided into two groups: (i) group 1 received herbal drug EPs® 7630 by oral route \[Umca® solution; (3x10 drops; between 1-5 years of age, 3x20 drops; 6-12 years of age, 3x30 drops for children \>12 years of age)\] for 7 days.
- control grup (Type: NO_INTERVENTION): Control group did not receive any herbal medication.

Based on this trial design, predict the completion outcome and termination type (if applicable).